Receptos (RCPT) PT Lifted to $201 at Wedbush

Wedbush analyst Liana Moussatos reiterated a Outperform rating and boosted her price target on Receptos, Inc (NASDAQ: RCPT) to $201.00 (from $160.00) following Q4 results.

The analyst noted Receptos ended 2014 with about $671.9MM in cash and equivalents. They project this will provide runway into mid-2018.

Next ups for the company is additional TOUCHSTONE analyses to be disclosed in an oral plenary presentation at Digestive Disease Week (DDW, May 16-19, Washington, DC).

For an analyst ratings summary and ratings history on Receptos, Inc click here. For more ratings news on Receptos, Inc click here.

Shares of Receptos, Inc closed at $124.99 yesterday.

You May Also Be Interested In

• Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'
• Freedom Broker Downgrades Holley (HLLY) to Hold